Stocks and Investing Stocks and Investing
Mon, September 14, 2020
Fri, September 11, 2020

Mike Polark Initiated (ABT) at Buy and Held Target at $124 on, Sep 11th, 2020


Published on 2024-10-27 13:14:12 - WOPRAI, Mike Polark
  Print publication without navigation


Mike Polark of Wolfe Research, Initiated "Abbott Laboratories" (ABT) at Buy and Held Target at $124 on, Sep 11th, 2020.

Mike has made no other calls on ABT in the last 4 months.



There are 8 other peers that have a rating on ABT. Out of the 8 peers that are also analyzing ABT, 1 agrees with Mike's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Danielle Antalffy of "SVB Leerink" Maintained at Hold with Increased Target to $110 on, Friday, July 17th, 2020


These are the ratings of the 7 analyists that currently disagree with Mike


  • Matt Miksic of "Credit Suisse" Maintained at Buy with Increased Target to $136 on, Monday, August 31st, 2020
  • Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Increased Target to $130 on, Friday, August 28th, 2020
  • David Lewis of "Morgan Stanley" Maintained at Buy with Increased Target to $112 on, Thursday, August 27th, 2020
  • Rick Wise of "Stifel" Maintained at Strong Buy with Increased Target to $115 on, Thursday, August 27th, 2020
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $115 on, Thursday, August 27th, 2020
  • David Toung of "Argus Research" Maintained at Strong Buy with Increased Target to $125 on, Thursday, July 23rd, 2020
  • John Sourbeer of "UBS" Maintained at Strong Buy with Increased Target to $110 on, Friday, July 17th, 2020
Contributing Sources